Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Summary
This study is a multicenter, open-label, non-randomized, dose-finding Phase I study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with severe alopecia areata (AA).
Official title: A Phase I Study to Evaluate the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
Key Details
Gender
All
Age Range
12 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-09-30
Completion Date
2027-12-30
Last Updated
2026-08-13
Healthy Volunteers
No
Conditions
Interventions
VC005 tablets
VC005 repeat administration for 24 weeks
Locations (1)
The Peking University People's Hospital
Beijing, Beijing Municipality, China